Fierce Healthcare October 14, 2020
UnitedHealth Group unveiled its Level2 digital therapy platform for patients with diabetes earlier this year, and CEO David Wichmann said the company sees more opportunity to continue developing such therapies.
“Our growing therapeutics capacities are positively impacting the management of chronic diseases,” Wichmann said on a call with investors Wednesday morning.
Level2, which UHG revelead in July, provides eligible members with type 2 diabetes with a slate of connected devices they can use to track their conditions. They also receive one-on-one coaching with the goal of helping them achieve a healthier lifestyle.
The program aims to significantly improve the lives of its members, including helping some achieve remission.
Wichmann said that the Level2 platform, which also uses artificial intelligence to...
Today's Sponsors
Today's Sponsor